Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion1[S]

Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion1[S]

Humans and mice lacking angiopoietin-like protein 3 (ANGPTL3) have pan-hypolipidemia. ANGPTL3 inhibits two intravascular lipases, LPL and endothelial lipase, and the low plasma TG and HDL-cholesterol levels in ANGPTL3 deficiency reflect increased activity of these enzymes. The mechanism responsible...

Full description

Bibliographic Details
Main Authors:	Yan Wang, Viktoria Gusarova, Serena Banfi, Jesper Gromada, Jonathan C. Cohen, Helen H. Hobbs
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	Journal of Lipid Research
Subjects:	cholesterol dyslipidemias lipase/endothelial lipase/lipoprotein angiopoietin-like protein 3 very low density lipoprotein
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520355498

Similar Items

ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys1[S]
by: Viktoria Gusarova, et al.
Published: (2015-07-01)

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
by: Fredrik Landfors, et al.
Published: (2023-01-01)

ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
by: Mingjuan Deng, et al.
Published: (2022-07-01)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
by: Kelli L. Sylvers-Davie, et al.
Published: (2021-01-01)

Effect of an anti-lipoprotein lipase serum on plasma triglyceride removal
by: I P Kompiang, et al.
Published: (1976-09-01)

Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
by: Pei-Yi Chen, et al.
Published: (2021-07-01)

A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase
by: Kazuya Miyashita, et al.
Published: (2017-08-01)

Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
by: Tiwari Hemant K, et al.
Published: (2011-08-01)

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
by: Juan Carlos Quevedo-Abeledo, et al.
Published: (2022-05-01)

Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL
by: Xuchen Hu, et al.
Published: (2017-01-01)

Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency
by: Agnieska Ćwiklińska, et al.
Published: (2018-06-01)

Lipolytic remnants of human VLDL produced in vitro: effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants
by: Byung Hong Chung, et al.
Published: (2000-02-01)

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids[S]
by: Yan Q. Chen, et al.
Published: (2020-08-01)

CRISPR/Cas9-mediated Angptl8 knockout suppresses plasma triglyceride concentrations and adiposity in rats
by: Ryota Izumi, et al.
Published: (2018-09-01)

Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
by: Shi-Qin Xiang, et al.
Published: (1999-09-01)

A method for the determination of lipoprotein lipase in postheparin plasma and body tissues utilizing a triolein-coated Celite substrate
by: Israel Posner, et al.
Published: (1971-11-01)

Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-γ
by: Stewart C. Whitman, et al.
Published: (1999-06-01)

A randomised, controlled, crossover study of the effect of diet on angiopoietin-like protein 4 (ANGPTL4) through modification of the gut microbiome
by: Trine Blædel, et al.
Published: (2016-01-01)

Angiopoietin‐Like Protein 4 Is a High‐Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type‐2 Diabetic Patients
by: Long‐Yan Yang, et al.
Published: (2017-11-01)

A role of apolipoprotein D in triglyceride metabolism[S]
by: German Perdomo, et al.
Published: (2010-06-01)

Brown adipose tissue takes up plasma triglycerides mostly after lipolysis
by: Padmini P.S.J. Khedoe, et al.
Published: (2015-01-01)

The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis
by: Jeltje R. Goudriaan, et al.
Published: (2004-08-01)

ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure
by: Wieneke Dijk, et al.
Published: (2015-10-01)

ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
by: Xun Chi, et al.
Published: (2017-10-01)

ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance[S]
by: Jorge F. Haller, et al.
Published: (2017-06-01)

GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins
by: Anne P. Beigneux, et al.
Published: (2009-01-01)

Energy expenditure, insulin, and VLDL-triglyceride production in humans
by: Lars C. Gormsen, et al.
Published: (2006-10-01)

The influence of fasting/refeeding on the lipoprotein lipase activity of adipose tissue and muscle
by: L.M. Botion
Published: (2001-11-01)

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases
by: Xin Su, et al.
Published: (2018-01-01)

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
by: Svetlana Schekatolina, et al.
Published: (2022-07-01)

The transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activity
by: Salam Ibrahim, et al.
Published: (2007-07-01)

The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
by: Ren Zhang
Published: (2016-01-01)

Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits
by: William G. Hoffmann, et al.
Published: (2024-02-01)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
by: Yukihito Higashi
Published: (2023-05-01)

Flow‐Induced Secretion of Endothelial Heparanase Regulates Cardiac Lipoprotein Lipase and Changes Following Diabetes
by: Chae Syng Lee, et al.
Published: (2022-12-01)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
by: Laura de Armas-Rillo, et al.
Published: (2022-04-01)

Polimorfismo S447X da lipase lipoprotéica: influência sobre a incidência de doença arterial coronariana prematura e sobre os lípides plasmáticos The S447X polymorphism of lipoprotein lipase: effect on the incidence of premature coronary disease and on plasma lipids
by: Kátia A. Almeida, et al.
Published: (2007-03-01)

Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues
by: Qiaoling Yao, et al.
Published: (2013-04-01)

ANGPTL3 (Angiopoietin‐Like 3) Preferentially Resides on High‐Density Lipoprotein in the Human Circulation, Affecting Its Activity
by: Jordan M. Kraaijenhof, et al.
Published: (2023-11-01)

The beneficial effects of a water-based aerobic exercise session on the blood lipids of women with dyslipidemia are independent of their training status
by: Rochelle Rocha Costa, et al.